Moderna Inc. was hit with a new lawsuit alleging the vaccine maker’s Spikevax Covid-19 shots infringe 10 CureVac SE patents ...
This week, the European Commission authorized Moderna to market the vaccine, mRNA-1083 or mCOMBRIAX, making it the world’s ...
The EMA has recommended updating Comirnaty 10 mg formulations, including JN.1, KP.2, and LP.8.1 versions, to allow COVID-19 vaccination in individuals aged 6 months or older.
Morning Overview on MSN
Europe becomes first to authorize Moderna’s combined flu-COVID mRNA shot
Starting this autumn, adults aged 50 and older across the European Union may be able to roll up their sleeve just once and ...
COMBRIAX is the world's first flu plus COVID combination vaccine to receive marketing authorization and Moderna's ...
Sanofi’s protein-based vaccine Nuvaxovid has conquered Moderna’s next-generation messenger RNA shot mNexspike in a ...
Add Yahoo as a preferred source to see more of our stories on Google. A nurse draws up doses of the Moderna COVID-19 for a vaccination clinic in St. Helena in 2021. Moderna is offering a new, low-dose ...
Americans may face the next respiratory disease season without clear guidance for COVID shots and updated flu vaccines after ...
It's an anniversary no one wants to celebrate, but an anniversary nonetheless. Thursday, March 19, marked six years since the first COVID-19 lockdown was implemented in the United States. And while it ...
Morning Overview on MSN
EU clears Moderna’s combined flu-COVID shot for older adults
Older adults across the European Union are a step closer to replacing two annual jabs with one. In late February 2026, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results